E. Arne Høiby

7.7k citations

155 papers · 6.0k indexed · 1 hit paper · h-index 39

Epidemiology top 0.5%
Microbiology top 0.02%
Infectious Diseases top 1%
Public Health, Environmental and Occupational Health top 1%
Immunology top 5%

Co-authors: Dominique A. Caugant Einar Rosenqvist L O Frøholm Elisabeth Wedege G Bjune Ingeborg S. Aaberge Hanne Nøkleby Alfred Halstensen
Topics: Bacterial Infections and Vaccines (82 papers)Pneumonia and Respiratory Infections (81 papers)Streptococcal Infections and Treatments (21 papers)
Cited by: Microbiology Epidemiology Endocrinology
Journals: Proceedings of the National Academy of Sciences The Lancet JAMA
Partner nations: Norway United States Poland

In The Last Decade

E. Arne Høiby

149 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1991 583 citations G Bjune, E. Arne Høiby et al. The Lancet profile →

Peers

Countries citing papers authored by E. Arne Høiby

Since Specialization

Citations

This map shows the geographic impact of E. Arne Høiby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Arne Høiby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Arne Høiby more than expected).

Fields of papers citing papers by E. Arne Høiby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Arne Høiby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Arne Høiby. The network helps show where E. Arne Høiby may publish in the future.

Co-authorship network of co-authors of E. Arne Høiby

This figure shows the co-authorship network connecting the top 25 collaborators of E. Arne Høiby. A scholar is included among the top collaborators of E. Arne Høiby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Arne Høiby. E. Arne Høiby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel Direct MIC-gradient Strip Method to screen for antibiotic-resistant faecal Enterobacteriaceae 2016 ·Journal of Microbiological Methods ·Karianne Wiger Gammelsrud,Per Kristian Knudsen,E. Arne Høiby	2
2	Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial 2016 ·Clinical Microbiology and Infection ·Dag Torfoss,(unknown),(unknown),Lorentz Brinch,Fredrik Schjesvold,Yngvar Fløisand,O. Nyquist,Jakob Dalgaard,Peter Meyer,Anne Kristine Lehmann,Jens Hammerstrøm,Tove Skjelbakken,E. Arne Høiby,Leiv Sandvik,Stein Kvaløy	7
3	Colonization by Candida in children with cancer, children with cystic fibrosis, and healthy controls 2011 ·Clinical Microbiology and Infection ·Karianne Wiger Gammelsrud,Per Sandven,E. Arne Høiby,Leiv Sandvik,P Brandtzæg,Peter Gaustad	32
4	Bakteriell resistens mot antibiotika 2008 ·Tidsskrift for Den Norske Laegeforening ·E. Arne Høiby,Didrik F. Vestrheim,Dominique A. Caugant,Karianne Wiger Gammelsrud	0
5	Salmonella diarizonae hos dyr i Norge Konsekvenser for dyr og mennesker. Uttalelse av Faggruppe for hygiene og smittestoffer og Faggruppe for dyrehelse og dyrevelferd (dyrevern) 2008 ·BIBSYS Brage (BIBSYS (Norway)) ·Truls Nesbakken,Jørgen Fr Lassen,Karin Nygård,O. Østerås,E. Arne Høiby,Georg Kapperud,Bjørn Tore Lunestad,Ørjan Olsvik,Lucy J. Robertson,Michael A. Tranulis,Morten Tryland,Espen Rimstad	1
6	Risk assessment of import and dissemination of intestinal pathogenic bacteria via fresh herbs and leafy vegetables from South-East Asia. Opinion of the Panel on Biological Hazards 2008 ·Duo Research Archive (University of Oslo) ·(unknown),Gro S. Johannessen,E. Arne Høiby,Georg Kapperud,Bjørn Tore Lunestad,Truls Nesbakken,Karin Nygård,Ørjan Olsvik,Lucy J. Robertson,Michael A. Tranulis,Morten Tryland,Espen Rimstad	6
7	Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway 2008 ·Vaccine ·Didrik F. Vestrheim,Ø Løvoll,Ingeborg S. Aaberge,Dominique A. Caugant,E. Arne Høiby,(unknown),(unknown)	144
8	Brucellar mastitis: presentation of a case and review of the literature 2007 ·International Journal of Infectious Diseases ·Mogens Jensenius,Nils Olav Hermansen,(unknown),Dominique A. Caugant,E. Arne Høiby,Sirkka Vene,Bent von der Lippe	6
9	Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial 2007 ·Journal of Antimicrobial Chemotherapy ·Dag Torfoss,E. Arne Høiby,Jon Magnus Tangen,Harald Holte,(unknown),Peter Meyer,Kjell A. Grøttum,(unknown),Grete F. Lauritzsen,Berit Sandstad,Anne-Birgitte Jacobsen,Harald Olsen,Stein Kvaløy	19
10	High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985–2002 2006 ·Epidemiology and Infection ·(unknown),Dominique A. Caugant,E. Arne Høiby,Tore Wentzel‐Larsen,Alfred Halstensen	24
11	Carriage of Streptococcus pneumoniae in healthy Norwegian children attending day-care centres 2006 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown),Ingeborg S. Aaberge,(unknown),E. Arne Høiby,L O Frøholm,(unknown),Dominique A. Caugant	7
12	Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal Disease 2004 ·Journal of Clinical Microbiology ·Reidun Øvstebø,P Brandtzæg,Berit Brusletto,Kari Bente Foss Haug,Knut Lande,E. Arne Høiby,Peter Kierulf	91
13	Emerging antibiotic resistance in Salmonella Typhimurium in Norway 2000 ·Epidemiology and Infection ·Truls Michael Leegaard,(unknown),L O Frøholm,E. Arne Høiby,Jørgen Fr Lassen	14
14	The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci1Presented in part at The Tenth International Pathogenic Neisseria Conference, Baltimore, MD, USA, September 8–13, 1996.1 1999 ·Vaccine ·Maija Toropainen,Helena Käyhty,Leena Saarinen,Einar Rosenqvist,E. Arne Høiby,Elisabeth Wedege,Terje E. Michaelsen,P. Helena Mäkelä	26
15	Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication 1999 ·Epidemiology and Infection ·(unknown),Anne Kristine Lehmann,(unknown),A Digranes,Dominique A. Caugant,E. Arne Høiby,L O Frøholm,Alfred Halstensen	19
16	Immunogenicity of Two Efficacious Outer Membrane Protein‐Based Serogroup B Meningococcal Vaccines among Young Adults in Iceland 1998 ·The Journal of Infectious Diseases ·Bradley A. Perkins,Kristín Jónsdóttir,(unknown),Elwyn Griffiths,Bonnie Plikaytis,E. Arne Høiby,Einar Rosenqvist,Jens J. Holst,Hanne Nøkleby,Franklin Sotolongo,Gustavo Sierra,(unknown),G M Carlone,Deniece R. Williams,Janet K. Dykes,Darrell R. Kapczynski,E Tikhomirov,Jay D. Wenger,Claire V. Broome	148
17	Lipopolysaccharide heterogeneity and escape mechanisms ofNeisseria meningitidis: possible consequences for vaccine development 1997 ·Microbial Pathogenesis ·Svein Rune Andersen,Jan Kolberg,E. Arne Høiby,Ellen Namork,Dominique A. Caugant,L O Frøholm,Erik Jantzen,Gunnar Bjune	18
18	Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features 1994 ·The Lancet ·(unknown),Julia Chelsom,Alfred Halstensen,(unknown),E. Arne Høiby	193
19	Spectrum of disease in bacteraemic patients during aStreptococcus pyogenes serotype M-1 epidemic in Norway in 1988 1992 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown),Peter R. Martin,E. Arne Høiby,Alfred Halstensen,(unknown),Kjell B. Hellum,Lars Westlie,Stein Hallan	28
20	Characteristics of Serogroup A Neisseria meningitidis Responsible for an Epidemic in Ethiopia, 1988-89 1990 ·Scandinavian Journal of Infectious Diseases ·Redda Tekle Haimanot,Dominique A. Caugant,Daniel Fekadu,G Bjune,(unknown),L O Frøholm,E. Arne Høiby,Einar Rosenqvist,Robert K. Selander,Bjarne Bjorvatn	22

About E. Arne Høiby

E. Arne Høiby is a scholar working on Microbiology, Epidemiology and Endocrinology, having authored 155 papers that have together received 6.0k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (82 papers), Pneumonia and Respiratory Infections (81 papers) and Streptococcal Infections and Treatments (21 papers). The work is most often cited by research in Microbiology (3.6k citations), Epidemiology (3.8k citations) and Endocrinology (415 citations). E. Arne Høiby has collaborated with scholars based in Norway, United States and Poland. Frequent co-authors include Dominique A. Caugant, Einar Rosenqvist, L O Frøholm, Elisabeth Wedege, G Bjune, Ingeborg S. Aaberge, Hanne Nøkleby, Alfred Halstensen, Peter R. Martin and Terje E. Michaelsen. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact